Seraphim’s investment portfolio boosted by space startup funding rounds

Seraphim’s investment portfolio boosted by space startup funding rounds

Seraphim Space Investment Trust (SSIT) witnessed a 1.4% increase in the total value of early-stage space investments, reaching 201 million pounds (7 million). Despite facing a setback from Astroscale’s discounted IPO on June 5, the London-listed trust managed to maintain its growth.

Astroscale’s decision to sell shares at a 40% discount compared to a private financing round last year led SSIT to reduce the valuation of its interest in the venture. Nonetheless, this adjustment only represented a small fraction of the trust’s investment portfolio.

Furthermore, the trust also marked down the value of its interest in AST SpaceMobile following share price declines but saw a rebound after securing a commercial agreement with U.S. telco AT&T. This positive development led to an increase in the stock price of AST SpaceMobile by more than 92% since the beginning of the year.

Despite the disappointing IPO of Astroscale, SSIT’s CEO Mark Boggett highlighted the oversubscription it received, indicating the market’s interest in space-related companies. Additionally, Astroscale’s shares performed well after the debut, bringing the trust’s holding close to its previous fair value.

Astroscale is the fourth SSIT investment to go public since the trust’s IPO in July 2021, demonstrating the growing public market appetite for space companies. The trust’s top holdings include Iceye, D-Orbit, All.Space, HawkEye 360, LeoLabs, SatVu, Xona Space Systems, Astroscale, PlanetWatchers, and Tomorrow.io.

Notable funding rounds by D-Orbit and Xona Space Systems contributed to SSIT’s overall fair value gain, along with positive developments in currency exchange rates and the valuation of its investment in Spire Global.

The trust’s portfolio is well-funded for the next 12 months, with 61% fully funded. In an effort to focus on more mature growth assets, SSIT sold its stakes in nine companies to Seraphim Space Ventures II, a new 0 million fund. This strategic move aims to ensure that the trust has the necessary cash reserves to meet funding requirements for the year ahead and beyond.

With a positive outlook for the portfolio in 2024 and 25.7 million pounds in cash reserves reported as of March 31, SSIT remains optimistic about its investment prospects in the space industry.

spot_img

More from this stream

Recomended

vivo V80 Redefines Smartphone Photography in the Middle East

PRWire

vivo launches the V80 in the UAE and Saudi Arabia, with four ZEISS co-engineered cameras, a 7,200mAh battery and 90W FlashCharge.

PRWire Press release Distribution Service.

Veracyte Says Decipher Prostate Test Predicts Abiraterone Benefit

PRWire

Veracyte’s research examines how tumour genomic information could help identify patients who benefit from treatment intensification with abiraterone.

PRWire Press release Distribution Service.

DeepSeek and MiniMax Complete Registration for Overseas AI Model Use

PRWire

DeepSeek and MiniMax have reportedly completed registrations covering open-source releases and overseas licensing as China reviews AI technology export controls.

PRWire Press release Distribution Service.

What Is GEO? A Practical Guide to Generative Engine Optimization

PRWire

Generative engine optimization (GEO) improves content for discovery and representation in AI-powered search. It builds on SEO through useful answers, clear brand information, accessible pages and evidence. PRWire can contribute through company news publication and distribution, without guaranteeing AI citations or recommendations.

PRWire Press release Distribution Service.

$42.5 Million Arbitration Award in Bitcoin Latinum Case Raises Questions About Damages Calculation in Cryptocurrency Litigation

PRWire

LOS ANGELES, Calif. — 10/23/2026 — A $42.5 million arbitration award granted to California investor Arshad Assofi against Bitcoin Latinum has...

PRWire Press release Distribution Service.

Lundbeck Names Lars Fruergaard Jørgensen as Proposed Next Chair

PRWire

The former Novo Nordisk CEO is expected to succeed Dorothea Wenzel following Lundbeck’s 2027 annual general meeting, subject to shareholder...

PRWire Press release Distribution Service.